Comparison of Oncotype DX® Recurrence Score® with other risk assessment tools including the Nottingham Prognostic Index in the identification of patients with low-risk invasive breast cancer
Crossref DOI link: https://doi.org/10.1007/s00428-017-2184-1
Published Online: 2017-07-14
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cotter, Maura Bríd
Dakin, Alex
Maguire, Aoife
Walshe, Janice M.
Kennedy, M. John
Dunne, Barbara
Riain, Ciarán Ó.
Quinn, Cecily M.
Funding for this research was provided by:
Pathological Society of Great Britain and Ireland
License valid from 2017-07-14